Medicare Enrolled
Dr. Thomas Pitoscia, M.D.
Adolescent Medicine · Millburn, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pitoscia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pitoscia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pitoscia
Dr. Thomas Pitoscia is an adolescent medicine specialist in Millburn, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Pitoscia performed 1,833 Medicare services across 371 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pitoscia received a total of $11,904 from 66 pharmaceutical and/or device companies across 846 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in adolescent medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pitoscia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 50% volume in NJ
$11,904 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,833
Medicare services
Top 50% in NJ for adolescent medicine
371
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~87 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,320 | $18 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $69 | $130 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $34 | $42 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
47 | $142 | $209 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
41 | $34 | $42 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
40 | $282 | $330 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
32 | $76 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $13 | $47 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $107 | $190 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
18 | $72 | $76 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
17 | $13 | $32 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,904
Total received (2018-2024)
Avg $1,701/year across 7 years
Top 20% in NJ for adolescent medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
846
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,904 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,379
2023
$1,624
2022
$1,911
2021
$1,852
2020
$1,716
2019
$1,313
2018
$2,108
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$269
Amgen Inc.
$214
Lilly USA, LLC
$129
IDORSIA PHARMACEUTICALS US INC
$122
GlaxoSmithKline, LLC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Exact Sciences Corporation
$76
AstraZeneca Pharmaceuticals LP
$69
PFIZER INC.
$63
Azurity Pharmaceuticals, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
QIAGEN, LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Almatica Pharma LLC
$16
Otsuka America Pharmaceutical, Inc.
$15
Vanda Pharmaceuticals Inc.
$14
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,783
Amgen Inc.
$1,746
Boehringer Ingelheim Pharmaceuticals, Inc.
$951
Janssen Pharmaceuticals, Inc
$843
GlaxoSmithKline, LLC.
$687
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$627
Amarin Pharma Inc.
$389
Lilly USA, LLC
$385
AstraZeneca Pharmaceuticals LP
$368
PFIZER INC.
$301
Merck Sharp & Dohme Corporation
$299
SANOFI-AVENTIS U.S. LLC
$286
Kowa Pharmaceuticals America, Inc.
$255
ARBOR PHARMACEUTICALS, INC.
$238
IBSA Pharma Inc.
$221
Otsuka America Pharmaceutical, Inc.
$205
Genentech USA, Inc.
$187
Bayer HealthCare Pharmaceuticals Inc.
$179
IDORSIA PHARMACEUTICALS US INC
$168
Bayer Healthcare Pharmaceuticals Inc.
$158
Novartis Pharmaceuticals Corporation
$136
Exact Sciences Corporation
$100
Eisai Inc.
$92
Takeda Pharmaceuticals U.S.A., Inc.
$91
Collegium Pharmaceutical, Inc.
$91
Gilead Sciences, Inc.
$83
Biohaven Pharmaceuticals, Inc.
$70
Azurity Pharmaceuticals, Inc.
$69
Alexion Pharmaceuticals, Inc.
$56
Shire North American Group Inc
$55
Almatica Pharma LLC
$46
AbbVie Inc.
$44
SCILEX PHARMACEUTICALS INC.
$42
Teva Pharmaceuticals USA, Inc.
$42
Zyla Life Sciences
$40
Bausch Health US, LLC
$38
Dynavax Technologies Corporation
$37
DEXCOM, INC.
$32
Althera Pharmaceuticals LLC
$30
Sunovion Pharmaceuticals Inc.
$28
Scilex Pharmaceuticals Inc.
$27
Medicure Pharma Inc.
$26
Astellas Pharma US Inc
$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
QIAGEN, LLC
$18
Incyte Corporation
$17
VBI Vaccines (Delaware) Inc.
$17
Promius Pharma LLC
$15
SANOFI PASTEUR INC.
$15
Xeris Pharmaceuticals, Inc.
$15
KADMON PHARMACEUTICALS LLC
$15
Antares Pharma, Inc.
$14
Daiichi Sankyo Inc.
$14
PROTEGA PHARMACEUTIALS LLC
$14
Purdue Pharma L.P.
$14
Vanda Pharmaceuticals Inc.
$14
ANI Pharmaceuticals, Inc.
$14
Celgene Corporation
$14
Neos Therapeutics, LP
$14
Horizon Therapeutics plc
$14
Seqirus USA Inc
$13
Alfasigma USA, Inc.
$13
Biohaven Pharmaceutical Holding Company Ltd.
$12
Ironwood Pharmaceuticals, Inc
$12
Supernus Pharmaceuticals, Inc.
$11
Aytu BioScience, Inc
$11
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO ELLIPTA · APLENZIN · AREXVY · Adzenys XR-ODT · Aimovig · Amitiza · BELSOMRA · BEXSERO · BREATHTEK · BREO · BREZTRI · BREZTRI AEROSPHERE · CAPLYTA · CHANTIX · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUZALLO · Dayvigo · EDARBYCLOR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FANAPT · FARXIGA · FLUZONE HIGH-DOSE · Fluad · GEMTESA · GLYXAMBI · GVOKE PFS · HORIZANT · Heplisav-B · Horizant · INVOKAMET · INVOKANA · InderalXL · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LIVALO · LOREEV XR · LUCEMYRA · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Morphabond ER · NURTEC ODT · Natesto · OFEV · OPZELURA · Otezla · Otovel · Otrexup · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Roszet · Roxybond · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRIX · SYMPROIC · SYNTHROID · Saxenda · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Uloric · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG · ZYPITAMAG (pitavastatin) · Zelnorm · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Adolescent medicines within 10 mi
24
Per 100K population
2.8
County median income
$76,712
Nearest hospital
OVERLOOK MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pitoscia is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NJ peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pitoscia experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Pitoscia performed 1,320 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pitoscia receive payments from pharmaceutical companies?
Yes. Dr. Pitoscia received a total of $11,904 from 66 companies across 846 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pitoscia's costs compare to other adolescent medicines in Millburn?
Dr. Pitoscia's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pitoscia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adolescent Medicines in Millburn
Browse adolescent medicines in Millburn ranked by procedure volume and transparency data.
Highest volume
Top Adolescent Medicines in NJ
Adolescent medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adolescent Medicines in NJ
Which NJ adolescent medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology